BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22237406)

  • 41. Predictive modeling of aspirin-triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome.
    Yellepeddi VK; Baker OJ
    Clin Exp Dent Res; 2020 Apr; 6(2):225-235. PubMed ID: 32250566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function.
    Chattopadhyay R; Raghavan S; Rao GN
    Redox Biol; 2017 Aug; 12():438-455. PubMed ID: 28319894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.
    Kang JW; Lee SM
    Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1025-1035. PubMed ID: 27317426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro.
    Salas-Hernández A; Espinoza-Pérez C; Vivar R; Espitia-Corredor J; Lillo J; Parra-Flores P; Sánchez-Ferrer CF; Peiró C; Díaz-Araya G
    Mol Biol Rep; 2021 Jan; 48(1):57-66. PubMed ID: 33459958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.
    Mottola G; Chatterjee A; Wu B; Chen M; Conte MS
    PLoS One; 2017; 12(3):e0174936. PubMed ID: 28362840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury.
    Eickmeier O; Seki H; Haworth O; Hilberath JN; Gao F; Uddin M; Croze RH; Carlo T; Pfeffer MA; Levy BD
    Mucosal Immunol; 2013 Mar; 6(2):256-66. PubMed ID: 22785226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitory effects of aspirin-triggered resolvin D1 on spinal nociceptive processing in rat pain models.
    Meesawatsom P; Burston J; Hathway G; Bennett A; Chapman V
    J Neuroinflammation; 2016 Sep; 13(1):233. PubMed ID: 27589850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistopathology of Sjögren's syndrome.
    Konttinen YT; Porola P; Konttinen L; Laine M; Poduval P
    Autoimmun Rev; 2006 Nov; 6(1):16-20. PubMed ID: 17110311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis.
    Zhao YL; Zhang L; Yang YY; Tang Y; Zhou JJ; Feng YY; Cui TL; Liu F; Fu P
    Chin Med J (Engl); 2016 May; 129(9):1100-7. PubMed ID: 27098797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploring Salivary Epithelial Dysfunction in Sjögren's Disease.
    Noll B; Beckman M; Bahrani Mougeot F; Mougeot JL
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome.
    Vosters JL; Landek-Salgado MA; Yin H; Swaim WD; Kimura H; Tak PP; Caturegli P; Chiorini JA
    Arthritis Rheum; 2009 Dec; 60(12):3633-41. PubMed ID: 19950301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation.
    Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
    Clin Exp Immunol; 2002 Feb; 127(2):386-92. PubMed ID: 11876766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation.
    Nunes VS; Abrahão O; Rogério AP; Serhan CN
    J Phys Chem B; 2023 Jul; 127(29):6479-6486. PubMed ID: 37428488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice.
    Zeng M; Szymczak M; Ahuja M; Zheng C; Yin H; Swaim W; Chiorini JA; Bridges RJ; Muallem S
    Gastroenterology; 2017 Oct; 153(4):1148-1159. PubMed ID: 28634110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Laminin isoform profiles in salivary glands in Sjögren's syndrome.
    Porola P; Mackiewicz Z; Laine M; Baretto G; Stegaev V; Takakubo Y; Takagi M; Ainola M; Konttinen YT
    Adv Clin Chem; 2011; 55():35-59. PubMed ID: 22126023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resolvin D1 protects against hepatic ischemia/reperfusion injury in rats.
    Zhang T; Shu HH; Chang L; Ye F; Xu KQ; Huang WQ
    Int Immunopharmacol; 2015 Sep; 28(1):322-7. PubMed ID: 26118631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
    Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjögren's syndrome.
    Fox PC; Speight PM
    Crit Rev Oral Biol Med; 1996; 7(2):144-58. PubMed ID: 8875029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
    Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
    Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.